Ningbo Ruiheyuan Biotechnology Co., Ltd. announced that it will receive CNY 192,000,000 in a round of funding on August 18, 2023. The transaction included participation from returning investor Medicalsystem Biotechnology Co., Ltd. to retain the majority stake in the company. The company will issue common shares in the transaction.

This has been approved in the 19th meeting of the 4th board of directors. Post-completion of the transaction the registered capital of the company will increase from CNY 1,000,000 to CNY 192,000,000.